Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:01 pm Purchase | 2026-06-30 | 13G | KAILERA THERAPEUTICS INC KLRA | Canada Pension Plan Investment Board | 7,304,688 5.600% | 7,304,688 (New Position) | Filing History |
| 2026-08-14 08:03 am Purchase | 2026-06-30 | 13G | KAILERA THERAPEUTICS INC KLRA | RTW Investments, LP | 10,776,820 8.300% | 10,776,820 (New Position) | Filing History |
| 2026-08-05 06:04 am Purchase | 2026-06-30 | 13G | KAILERA THERAPEUTICS INC KLRA | Jiangsu Hengrui Pharmaceuticals Co. Ltd. | 11,511,853 8.900% | 11,511,853 (New Position) | Filing History |
| 2026-04-23 8:01 pm Purchase | 2026-04-16 | 13D | KAILERA THERAPEUTICS INC KLRA | BCLS Fund IV Investments, L.P. | 22,583,268 17.430% | 22,583,268 (New Position) | Filing History |
| 2026-04-23 7:34 pm Purchase | 2026-04-16 | 13D | KAILERA THERAPEUTICS INC KLRA | BCPE Perseus Investor, LP | 26,255,581 20.270% | 26,255,581 (New Position) | Filing History |